JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

Tyrosine Kinase

B5832 Altiratinib
1 Citation

Target: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2

Summary: c-MET/TIE-2/VEGFR inhibitor

≥21.55 mg/mL
C4539 AG-370

Summary: PDGFR inhibitor

≤30 mg/mL
B7190 PP 3

Summary: Negative control for the Src kinase inhibitor PP 2

Soluble in DMSO
A8197 Compound 56
1 Citation

Target: EGFR

Summary: REGFR inhibitor

insoluble in H2O; ≥16.95 mg/mL
A5057 MGCD-265

Target: VEGFR|c-MET

Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor

≥25.9 mg/mL
A5455 AEE788 (NVP-AEE788)

Summary: EGFR/HER-2/VEGFR inhibitor

≥22.05 mg/mL
C4025 CEP-28122

Summary: anaplastic lymphoma kinase (ALK) inhibitor

≤30 mg/mL
B2302 ZM 323881 HCl

Summary: selective VEGFR2 inhibitor

Soluble in DMSO
B7354 SU 16f

Target: PDGFR

Summary: PDGFRβ inhibitor

Soluble in DMSO
B6891 Damnacanthal

Summary: p56lck tyrosine kinase inhibitor

<7.06 mg/mL